Preimplantation Genetic Diagnosis (PGD) Market by End-users and Geography - Global Forecast and Analysis 2019-2023

The global preimplantation genetic diagnosis market size has the potential to grow by USD 131.99 million during 2019-2023, and the market’s growth momentum will accelerate throughout the forecast period because of the steady increase in the year-over-year growth.

This report provides a detailed analysis of the market by geography (Asia, Europe, North America, and ROW) and end-users (fertility clinics and maternity centers, hospitals and diagnostic laboratories, and research institutes). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors, including Genea Ltd., Igenomix Sl, Illumina Inc., Invitae Corp., Laboratory Corp. of America Holdings, Natera Inc., Oxford Gene Technology Group, PerkinElmer Inc., Quest Diagnostics Inc., and Thermo Fisher Scientific Inc.

Market Overview

Browse TOC and LoE with selected illustrations and example pages of preimplantation genetic diagnosis market

Request a FREE sample now!

Market Competitive Analysis

The market is concentrated, and the degree of concentration will decrease during the forecast period. The key players in the market are focusing on various growth strategies such as mergers and acquisitions, divestitures, joint ventures, and partnerships to expand the geographical reach and gain major market shares and revenue. PerkinElmer Inc., Quest Diagnostics Inc., and Thermo Fisher Scientific Inc. are a few of the major market participants. Although the accelerating growth momentum will offer immense growth opportunities, concerns about safety and privacy of genetic data will challenge the growth of market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

To help clients improve their market positions, this preimplantation genetic diagnosis market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of these companies. The report also covers details on the market’s competitive landscape and offers information on the products offered by various companies. Moreover, this preimplantation genetic diagnosis market analysis report also provides information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.

This report provides information on the production, sustainability, and prospects of several leading preimplantation genetic diagnosis companies, including:

• Genea Ltd.
• Igenomix Sl
• Illumina Inc.
• Invitae Corp.
• Laboratory Corp. of America Holdings
• Natera Inc.
• Oxford Gene Technology Group
• PerkinElmer Inc.
• Quest Diagnostics Inc.
• Thermo Fisher Scientific Inc.

Preimplantation Genetic Diagnosis Market: Segmentation by Region